SPECT Clinical Trials in Houston, Texas
13 recruitingHouston, Texas
Showing 1–13 of 13 trials
Recruiting
Phase 2
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
PIK3CA-Related Overgrowth Spectrum (PROS)
Novartis Pharmaceuticals104 enrolled32 locationsNCT06997588
Recruiting
Phase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
PIK3CA MutationVascular AnomaliesVascular Malformations+5 more
Relay Therapeutics, Inc.277 enrolled34 locationsNCT06789913
Recruiting
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
Autism Spectrum Disorder
Stalicla SA1,500 enrolled21 locationsNCT05590715
Recruiting
Not Applicable
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
schizophrenia spectrum disorder
The University of Texas Health Science Center, Houston20 enrolled1 locationNCT07290738
Recruiting
Phase 2
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
Suspected or Known Squamous Cell NeoplasiaPrior History of Squamous Cell Dysplasia and /or Neoplasia
Baylor College of Medicine200 enrolled4 locationsNCT06435286
Recruiting
Not Applicable
A Trial of the Launching! to Adulthood Program
Autism Spectrum Disorder (ASD)
The University of Texas Health Science Center, Houston40 enrolled1 locationNCT06868537
Recruiting
Not Applicable
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
AnxietyAutismAutism Spectrum Disorder+3 more
Baylor College of Medicine139 enrolled1 locationNCT06537128
Recruiting
Not Applicable
Application of Virtual Reality Technology to Treatment of Social Anxiety
Autism Spectrum DisorderSocial Anxiety Disorder
The University of Texas Health Science Center, Houston40 enrolled1 locationNCT06845488
Recruiting
Phase 3
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
SchizophreniaAutism Spectrum DisorderBipolar Disorder
Intra-Cellular Therapies, Inc.500 enrolled50 locationsNCT06229210
Recruiting
Phase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.174 enrolled39 locationsNCT06706674
Recruiting
Phase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.174 enrolled37 locationsNCT06690398
Recruiting
Phase 1Phase 2
Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
Autism Spectrum DisorderGastrointestinal Symptoms
The University of Texas Health Science Center, Houston70 enrolled1 locationNCT03514784
Recruiting
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
Antibiotic Resistant InfectionCarbapenem-Resistant Enterobacteriaceae InfectionVancomycin Resistant Enterococci Infection+5 more
The Methodist Hospital Research Institute1,000 enrolled2 locationsNCT06258551